1. Home
  2. /
  3. Availability
  4. /
  5. Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals

Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals

Description

Phase 3 trial testing whether VPM1002 and immuvac can prevent microbiologically confirmed TB including pulmonary and extrapulmonary TB, in household contacts of people with smear-positive TB
TB vaccine theme
Availability
Epidemiological impact

Project details

Country
India
Timeline
2023
Target group
Household contact
Vaccine
Immuvac, VPM1002
Type of protection of vaccine
Prevention of disease
Type of research
Quantitative
Partners involved
Indian Council of Medical Research (ICMR), National Institute of Tuberculosis and Respiratory Diseases, Bhagwan Mahavir Medical Research Centre, and other participating Indian research centres
Type of project
Clinical Trial/ Vaccine research
Funder
Civil Society
Governmental Body

Resources

Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study

Contact

Manjual Singh
drmanjulasb@gmail.com
Click to copy link of this header Menu